Once-Nightly Pill AD109 Shows Promise as an Alternative Treatment for Sleep Apnea

AD109, a once-nightly oral pill, showed clinically meaningful benefits in a Phase 3 trial of 646 adults with obstructive sleep apnea. The medication reduced breathing interruptions by about 44% versus under 20%...



























